Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Seaport Therapeutics
Seaport Therapeutics operates as a clinical stage biopharmaceutical company.
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Organization
Company
B2X
B2C
CEO
Daphne Zohar
CMO
Antony Loebel, M.D.
Crunchbase URL
crunchbase.com/organiz...apeutics
Email Address
info@seaporttx.com
publicrelations@seaporttx.com
Founder
Daphne Zohar
Industry
Healthcare
Biotechnology
Pharmaceutical industry
Investors
Invus
Third Rock Ventures
ARCH Venture Partners
Sofinnova Investments
Goldman Sachs Alternatives
T. Rowe Price
General Atlantic
Latest Funding Round Date
October 21, 2024
Latest Funding Round Amount (USD)
225,000,000
Latest Funding Type
Series B Round
LinkedIn URL
@company/seaport-therapeutics
Location
Boston, Massachusetts, United States
Number of Employees (Ranges)
11 – 50
Total Funding Amount (USD)
225,000,000
Twitter URL
@SeaportTx
Official Website
seaporttx.com
Find more companies like Seaport Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE